Go Deep
Viyash Scientific Limited
Viyash Scientific Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,335 | 57.0 | 3.53 | 0.16 | 232.98 |
Viyash Scientific Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 9,463,600,000.0 | 9,199,600,000.0 | 8,584,100,000.0 | 4,239,900,000.0 |
| Net Profit | 658,700,000.0 | 521,100,000.0 | 384,400,000.0 | 147,400,000.0 |
| EPS | 1.5 | 1.2 | 0.9 | 0.6 |
Viyash Scientific Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 33,569,610,000.0 | 29,633,990,000.0 | 13,663,000,000.0 | 14,182,750,000.0 |
| Net Profit | 1,772,850,000.0 | 232,190,000.0 | -358,690,000.0 | -1,211,590,000.0 |
| EPS | 4.1 | 0.5 | -1.4 | -4.9 |
Viyash Scientific Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 46,283,870,000.0 | 41,322,660,000.0 | 15,403,840,000.0 | 15,291,230,000.0 | — |
| Total Liabilities | 15,136,590,000.0 | 15,673,300,000.0 | 8,274,250,000.0 | 7,799,330,000.0 | — |
| Total Equity | 29,110,600,000.0 | 24,315,870,000.0 | 6,565,600,000.0 | 6,987,780,000.0 | — |
Owes vs Owns
Viyash Scientific Limited owed ₹0.33 for every ₹1 it owned in Mar 2026, down from ₹0.51 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.33× | 0.38× | 0.54× | 0.51× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Viyash Scientific Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 5.8%Receivables 22.6%Inventory 17.4%Fixed assets (tangible) 26.1%Intangible assets 20.9%Other assets 7.1%
How it's funded — Mar 2026
Short-term debt 2.9%Long-term debt 6.5%Payables 12.9%Other liabilities 10.4%Shareholders' equity 67.3%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 269.7 | 149.5 | 68.8 | 41.6 |
| Receivables | 1,045.2 | 806.5 | 335.6 | 341.0 |
| Inventory | 803.2 | 682.2 | 346.2 | 346.1 |
| Fixed assets (tangible) | 1,208.4 | 1,147.6 | 311.5 | 352.3 |
| Intangible assets | 966.8 | 1,004.8 | 296.7 | 308.5 |
| Long-term investments | 6.7 | 4.5 | 7.5 | 7.1 |
| Other assets | 328.3 | 337.2 | 174.1 | 132.5 |
| Liabilities & equity | ||||
| Short-term debt | 133.7 | 255.4 | 308.6 | 247.8 |
| Long-term debt | 302.1 | 352.9 | 142.7 | 150.1 |
| Payables | 597.3 | 489.3 | 251.2 | 244.3 |
| Other liabilities | 480.6 | 469.7 | 124.9 | 137.7 |
| Shareholders' equity | 3,114.7 | 2,564.9 | 713.0 | 749.2 |
| Net tangible assets | 1,944.3 | 1,426.8 | 359.9 | 390.3 |
Viyash Scientific Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 3,229,130,000.0 | 3,447,990,000.0 | 305,950,000.0 | 168,080,000.0 | — |
| Investing Activities | -841,180,000.0 | -4,472,150,000.0 | -59,200,000.0 | -649,580,000.0 | — |
| Financing Activities | -1,233,340,000.0 | 870,350,000.0 | -14,390,000.0 | 322,280,000.0 | — |